Rare diseases
Investigational molecules
Locations
Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
ItalyStudy on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes
ItalyStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
ItalyEvaluation of Tirzepatide Versus Placebo in Adolescents with Obesity or Overweight and Weight-Related Comorbidities: A Randomized, Double-Blind Clinical Trial
ItalyEfficacy and Safety of Tirzepatide Versus Placebo in Adults with Type 1 Diabetes and Obesity or Overweight: A Phase 3 Randomized Controlled Trial
ItalyEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
ItalyStudy on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo
ItalyWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
ItalyEfficacy and safety of eplontersen sodium plus ALXN2220 in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)
ItalyEfficacy and Safety of E2086 in Adults with Narcolepsy: A Randomized, Double‑Blind, Placebo‑Controlled Trial
ItalyStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
ItalyA Phase 2 Study of JNJ-79635322 in Patients with Relapsed or Refractory Multiple Myeloma
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
